Horizon Space Acquisition II Corp. (HSPT)
Automate Your Wheel Strategy on HSPT
With Tiblio's Option Bot, you can configure your own wheel strategy including HSPT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HSPT
- Rev/Share 0.0
- Book/Share 10.305
- PB -168.2719
- Debt/Equity 0.0
- CurrentRatio 0.2192
- ROIC -0.0147
- MktCap 96611200.0
- FreeCF/Share -0.1436
- PFCF -97.5321
- PE 49.0589
- Debt/Assets 0.0
- DivYield 0
- ROE 0.043
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Horizon Space Acquisition II Corp. Clarifies Redemption Process for Business Combination Shareholder Meeting and Extension Shareholder Meeting
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the “Company” or “HSPT”) (NASDAQ: HSPT) today clarified the redemption process for (i) the extraordinary general meeting for its proposed business combination (the “Business Combination”) with SL BIO Ltd. (“SL Bio”), which will be held on February 12, 2026 (the “Business Combination Meeting”), and (ii) the extraordinary general meeting for its proposed amendments to HSPT's current amended and restated memorandum and articles of association, and the Investment Management Trust Agreement (collectively, the “Extension Proposals”), to extend the deadline to complete its initial business combination, which will …
Read More
Horizon Space Acquisition II Corp. Announces Definitive Business Combination Agreement with SL Bio Ltd.
Published: May 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Horizon Space Acquisition II Corp. ("HSPT") (Nasdaq:HSPT), a publicly traded special purpose acquisition company, and SL Bio Ltd. ("SL Bio"), a clinical-stage biomedical company specialized in developing groundbreaking cellular and gene therapies for skin care and cancer recovery, today announced that they have entered into a definitive business combination agreement (the "Business Combination Agreement").
Read More
About Horizon Space Acquisition II Corp. (HSPT)
- IPO Date
- Website https://www.horizonacquisitionii.com
- Industry Shell Companies
- CEO Mingyu Li
- Employees 2